BioAces (Shanghai) Life Science Co., Ltd. established in 2020, is a high-tech enterprise that integrates the research, development, production, sales, and service of life science instruments. The company has a technical team with expertise in multiple interdisciplinary fields, and the core team members are from various departments of Peking University. We have submitted and obtained over 20 national invention and international PCT patents.
The company focuses on cell analysis and monitoring technologies for biological reactions in the field of life sciences. The company aspires to be an innovator and pioneer in live cell imaging and microfluidic chip technologies. Our team independently developed system is based on a microfluidic technology platform, utilizing cutting-edge optical analysis techniques and integrating artificial intelligence algorithms such as machine learning and deep learning. This enables multi-dimensional data modeling and visualization of the dynamic processes of live cells in biological reactions.
The core technologies of the company's products from the transformation of years of independent scientific research achievements. The product line includes real-time multimodal imaging of live cells, flow cytometry analysis, and high-content imaging analysis equipment. These products find wide applications in upstream process development of biologics, such as vaccines, ADC, mAbs, and CGT.
Since its establishment four years ago, the company has already launched two products into the market, with more in the pipeline. In December 2023, the company was awarded the title of high-tech enterprise. Continuously focusing on cell analysis and monitoring technologies in the field of life sciences, the company aims to facilitate the intelligent, automated, and simplified transformation of biopharmaceutical processes, empowering the high-quality development of the biopharmaceutical industry.
Wechat